Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse
Claus J. Løland, Maddalena Mereu, Oluyomi M. Okunola, et al.
Biological Psychiatry (2012) Vol. 72, Iss. 5, pp. 405-413
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik, Michael McDonnell, Catherine Mills, et al.
SLEEP (2019) Vol. 43, Iss. 4
Open Access | Times Cited: 183
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German, Michelle Baladi, Lisa M. McFadden, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1005-1024
Open Access | Times Cited: 166
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders
Maddalena Mereu, Antonello Bonci, Amy Hauck Newman, et al.
Psychopharmacology (2013) Vol. 229, Iss. 3, pp. 415-434
Open Access | Times Cited: 139
Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation
Yin Cao, Qinglin Li, Lulu Liu, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 9, pp. 1282-1297
Open Access | Times Cited: 130
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 1-19
Open Access | Times Cited: 126
Pharmacotherapy of amphetamine‐type stimulant dependence: An update
Matthew Brensilver, Keith G. Heinzerling, Steven Shoptaw
Drug and Alcohol Review (2013) Vol. 32, Iss. 5, pp. 449-460
Open Access | Times Cited: 121
Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial Substrates
Kyle C. Schmitt, Richard B. Rothman, Maarten E. A. Reith
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 346, Iss. 1, pp. 2-10
Open Access | Times Cited: 109
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Per Plenge, Dongxue Yang, Kristine Salomon, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 72
Structure of the human dopamine transporter in complex with cocaine
Jeppe C. Nielsen, Kristine Salomon, Iris E. Kalenderoglou, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 678-685
Closed Access | Times Cited: 10
An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil
Eric Murillo-Rodrı́guez, André Barciela Veras, Nuno Rocha, et al.
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 2, pp. 151-158
Closed Access | Times Cited: 82
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle Baladi, Michael J. Forster, Michael B. Gatch, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 2, pp. 367-376
Open Access | Times Cited: 79
Modafinil Abrogates Methamphetamine-Induced Neuroinflammation and Apoptotic Effects in the Mouse Striatum
Mariana Raineri, Betina González, Belén Goitia, et al.
PLoS ONE (2012) Vol. 7, Iss. 10, pp. e46599-e46599
Open Access | Times Cited: 77
Modafinil as a Catecholaminergic Agent: Empirical Evidence and Unanswered Questions
Jonathan P. Wisor
Frontiers in Neurology (2013) Vol. 4
Open Access | Times Cited: 76
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 65
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors
Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10676-10691
Open Access | Times Cited: 63
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology (2019) Vol. 158, pp. 107609-107609
Open Access | Times Cited: 62
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders
Amy Hauck Newman, Therese Ku, Chloe J. Jordan, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 61, Iss. 1, pp. 609-628
Open Access | Times Cited: 49
Overview of the structure and function of the dopamine transporter and its protein interactions
Binod Nepal, Sanjay Kumar Das, Maarten E. A. Reith, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 21
Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies
Panpan Wang, Xiaoyu Zhang, Tingting Fu, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1416-1428
Closed Access | Times Cited: 61
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Shi Hui Poon, Kang Sim, Ross J. Baldessarini
Current Neuropharmacology (2015) Vol. 13, Iss. 5, pp. 592-604
Open Access | Times Cited: 60
Pharmacological profile of methylphenidate-based designer drugs
Dino Luethi, Philine J. Kaeser, Simon D. Brandt, et al.
Neuropharmacology (2017) Vol. 134, pp. 133-140
Open Access | Times Cited: 55
Expanding the toolbox of Baeyer–Villiger and flavin monooxygenase biocatalysts for the enantiodivergent green synthesis of sulfoxides
Jingyue Wu, Silvia Anselmi, Alexandra T. P. Carvalho, et al.
Green Chemistry (2024) Vol. 26, Iss. 15, pp. 8685-8693
Open Access | Times Cited: 6
Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants
Heinz Steiner, Vincent Van Waes
Progress in Neurobiology (2012) Vol. 100, pp. 60-80
Open Access | Times Cited: 54
Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
Marilyne Uguen, David Perrin, Simon Belliard, et al.
British Journal of Pharmacology (2013) Vol. 169, Iss. 3, pp. 632-644
Open Access | Times Cited: 52
Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues
Oluyomi M. Okunola-Bakare, Jianjing Cao, Theresa Kopajtic, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 3, pp. 1000-1013
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top